Home

vtipný dovnútra nesúvisiace voriconazol mic Hlavu hore anjel hynú

CLSI MICs of fluconazole, voriconazole, itraconazole, and posaconazole... | Download Scientific Diagram
CLSI MICs of fluconazole, voriconazole, itraconazole, and posaconazole... | Download Scientific Diagram

MIC determination of voriconazole (VCZ) and amphotericin B (AMB)... | Download Scientific Diagram
MIC determination of voriconazole (VCZ) and amphotericin B (AMB)... | Download Scientific Diagram

MIC 80 values of fluconazole, itraconazole and voriconazole for... | Download Scientific Diagram
MIC 80 values of fluconazole, itraconazole and voriconazole for... | Download Scientific Diagram

PDF) Clinical Isolates of Aspergillus Species Remain Fully Susceptible to Voriconazole in the Post-Voriconazole Era | Teresa Peláez - Academia.edu
PDF) Clinical Isolates of Aspergillus Species Remain Fully Susceptible to Voriconazole in the Post-Voriconazole Era | Teresa Peláez - Academia.edu

MIC 90 values for voriconazole, natamycin, and amphotericin B (µg/mL) | Download Table
MIC 90 values for voriconazole, natamycin, and amphotericin B (µg/mL) | Download Table

JoF | Free Full-Text | Comparison of Antimycotic Activity of Originator and Generics of Voriconazole and Anidulafungin against Clinical Isolates of Candida albicans and Candida glabrata
JoF | Free Full-Text | Comparison of Antimycotic Activity of Originator and Generics of Voriconazole and Anidulafungin against Clinical Isolates of Candida albicans and Candida glabrata

How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST) - Clinical Microbiology and Infection
How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST) - Clinical Microbiology and Infection

Liofilchem MTS Voriconazole [VO] 0.002-32 g/mL 100/Pack, Packed by 10:Microbiology | Fisher Scientific
Liofilchem MTS Voriconazole [VO] 0.002-32 g/mL 100/Pack, Packed by 10:Microbiology | Fisher Scientific

Candida glabrata | 2004-10-01 | AHC Media: Continuing Medical…
Candida glabrata | 2004-10-01 | AHC Media: Continuing Medical…

xmlinkhub
xmlinkhub

Evaluation of Susceptibility to Fluconazole and Voriconazole in Oral Candida glabrata Isolates from Drug Addicts | International Journal of High Risk Behaviors and Addiction | Full Text
Evaluation of Susceptibility to Fluconazole and Voriconazole in Oral Candida glabrata Isolates from Drug Addicts | International Journal of High Risk Behaviors and Addiction | Full Text

Correlation of MIC with Outcome for Candida Species Tested against Voriconazole: Analysis and Proposal for Interpretive Breakpoints | Journal of Clinical Microbiology
Correlation of MIC with Outcome for Candida Species Tested against Voriconazole: Analysis and Proposal for Interpretive Breakpoints | Journal of Clinical Microbiology

Aspergillus fumigatus can display persistence to the fungicidal drug voriconazole | bioRxiv
Aspergillus fumigatus can display persistence to the fungicidal drug voriconazole | bioRxiv

Correlation of MIC with Outcome for Candida Species Tested against Voriconazole: Analysis and Proposal for Interpretive Breakpoints | Journal of Clinical Microbiology
Correlation of MIC with Outcome for Candida Species Tested against Voriconazole: Analysis and Proposal for Interpretive Breakpoints | Journal of Clinical Microbiology

MICs of amphotericin B, itraconazole, and voriconazole | Download Table
MICs of amphotericin B, itraconazole, and voriconazole | Download Table

Azole resistance survey on clinical Aspergillus fumigatus isolates in Spain - ScienceDirect
Azole resistance survey on clinical Aspergillus fumigatus isolates in Spain - ScienceDirect

How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST) - Clinical Microbiology and Infection
How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST) - Clinical Microbiology and Infection

Table 3 from Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria. | Semantic Scholar
Table 3 from Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria. | Semantic Scholar

Fluconazole and Voriconazole MIC 50% and MIC 90% obtained with the most... | Download Table
Fluconazole and Voriconazole MIC 50% and MIC 90% obtained with the most... | Download Table

VORICONAZOLE MIC Test Strip (0.002 - 32 μg/mL)]
VORICONAZOLE MIC Test Strip (0.002 - 32 μg/mL)]

Voriconazole MICs for Candida spp. calculated from disk zone diameter... | Download Table
Voriconazole MICs for Candida spp. calculated from disk zone diameter... | Download Table

Fluconazole and voriconazole MIC levels of C. tropicalis isolates... | Download Scientific Diagram
Fluconazole and voriconazole MIC levels of C. tropicalis isolates... | Download Scientific Diagram

A strategy for designing voriconazole dosage regimens to prevent invasive pulmonary aspergillosis based on a cellular pharmacokinetics/pharmacodynamics model | Journal of Translational Medicine | Full Text
A strategy for designing voriconazole dosage regimens to prevent invasive pulmonary aspergillosis based on a cellular pharmacokinetics/pharmacodynamics model | Journal of Translational Medicine | Full Text

In vitro susceptibility of a large collection of Candida strains against fluconazole and voriconazole by using the CLSI disk diffusion assay - Document - Gale Academic OneFile
In vitro susceptibility of a large collection of Candida strains against fluconazole and voriconazole by using the CLSI disk diffusion assay - Document - Gale Academic OneFile